Association between nonalcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.

Reply to "The role of NAFLD in extrahepatic malignancies: the importance of ruling out the effect of obesity".

Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma
Baracle® vs Baraclude® for 48 weeks in patients with treatment-na?ve chronic hepatitis B: a comparison of efficacy and safety.

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.

Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.

High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.

Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.

New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization.

Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.